default author photo

PanACEA Consortium Group

Independent

United States

SCHOLARLY PAPERS

4

DOWNLOADS

406

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

A Prospective, Randomised, Open Label Phase 2b Dose-Finding ​Trial of Delpazolid in Combination with Bedaquiline, Delamanid and Moxifloxacin for Pulmonary Tuberculosis: DECODE

Number of pages: 16 Posted: 10 Dec 2024
National Institute for Medical Research (NIMR), Radboud University Nijmegen - Radboud University Medical Center, National Institute for Medical Research (NIMR), Kibong’oto Infectious Diseases Hospital, Ifakara Health Institute, Ludwig Maximilian University of Munich (LMU), Aurum Institute, University of the Witwatersrand, Aurum Institute, National Institute for Medical Research (NIMR), Kibong’oto Infectious Diseases Hospital, Ifakara Health Institute, Ludwig Maximilian University of Munich (LMU), Ifakara Health Institute, Kibong’oto Infectious Diseases Hospital, Aurum Institute, University of St Andrews, Radboud University Nijmegen - Department of Lung Disease, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud Institute for Health Sciences, University College London, University College London, Radboud University Nijmegen - Department of Lung Disease, LigaChem Biosciences Inc, LigaChem Biosciences Inc, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Radboud University Nijmegen - Radboud Institute for Health Sciences, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine and Independent
Downloads 131 (554,631)

Abstract:

Loading...

Pulmonary tuberculosis, oxazolidinones, phase 2b, randomised clinical trial

2.

MAMS_6 - A Novel Transcriptome-Informed Quantitative Real-Time PCR-Based Signature for Monitoring Tuberculosis Treatment Success

Number of pages: 26 Posted: 02 May 2025
Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), National Institute for Medical Research (NIMR), University of Cape Town Lung Institute, Radboud University Nijmegen - Radboud University Medical Center, Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU), Ludwig Maximilian University of Munich (LMU) - Division of Paediatric Infectious Diseases, Ludwig Maximilian University of Munich (LMU) and Independent
Downloads 111 (635,507)

Abstract:

Loading...

Tuberculosis Diagnosis, Transcriptomics, RT-qPCR Biomarker

3.

Early Depressing Effect on Abundancy and Diversity of Sputum Microbiome Followed by Recovery During Anti-Tuberculosis Treatment: A Multi-Regimen Analysis of the High-Rifampicin II- and Multi-Arm-Multi-Stage Clinical Trials

Number of pages: 47 Posted: 27 Jul 2022
University of St. Andrews - Division of Infection and Global Health, University of Mpumalanga - School of Biology and Environmental Sciences, NHS Foundation Trust - Department of Microbiology, University of St. Andrews - Division of Infection and Global Health, University of St. Andrews - Division of Infection and Global Health, National Institute for Medical Research (NIMR), Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Kilimanjaro Christian Medical University College - Kilimanjaro Christian Medical Centre, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Radboud University Nijmegen - Department of Lung Disease, University of St. Andrews - Division of Infection and Global Health, University of St. Andrews - Division of Infection and Global Health and Independent
Downloads 100 (689,572)

Abstract:

Loading...

Sputum microbiome surrogate for respiratory microbiome, anti-tuberculosis antibiotics, tuberculosis treatment, impact on microbiome, anti-tuberculosis drug development strategies.

4.

Increased Bactericidal Activity But Dose-Limiting Tolerability at 50 mg/kg Rifampicin

Number of pages: 41 Posted: 31 Mar 2020
Radboud University Nijmegen - Department of Lung Disease, TASK Applied Science, University of Cape Town (UCT) - University of Cape Town Lung Institute, TASK Applied Science, Radboud University Nijmegen - Department of Pharmacy, University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, St. Andrews University, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University of Munich (LMU) - CIHLMU Center for International Health, University of Cape Town Lung Institute, TASK Applied Science, Radboud University Nijmegen - Department of Pharmacy, Radboud University Nijmegen - Department of Lung Disease and Independent
Downloads 64 (924,743)

Abstract:

Loading...

maximum tolerable dose; high-dose rifampicin; pharmacokinetics; early bactericidal activity; dose optimization; exposure-response